-
1دورية أكاديمية
المؤلفون: Arendrup, M.C., Meletiadis, J., Guinea, J., Friberg, N., Mares, M., Kahlmeter, G., Andersen, C.T., Arikan-Akdagli, S., Barchiesi, F., Chryssanthou, E., Hamal, P., Järv, H., Klimko, N., Kurzai, O., Lagrou, K., Lass-Flörl, C., Matos, T., Muehlethaler, K., Rogers, T.R., Velegraki, A., Arikan, S.
المصدر: In Clinical Microbiology and Infection November 2020 26(11):1464-1472
-
2دورية أكاديمية
المؤلفون: Arendrup, M.C., Arikan-Akdagli, S., Barchiesi, F., Castanheira, M., Chryssanthou, E., Friberg, N., Guinea, J., Järv, H., Klimko, N., Kurzai, O., Lagrou, K., Lass-Flörl, C., Mares, M., Matos, T., Meletiadis, J., Moore, C.B., Mouton, J.W., Muehlethaler, K., Rogers, T.R., Andersen, C.T., Velegraki, A., Verweij, P.E.
المصدر: In Clinical Microbiology and Infection June 2019 25(6):681-687
-
3مورد إلكتروني
المؤلفون: Arendrup, M.C. (Maiken Cavling), Friberg, N. (Nathalie), Mares, M. (Mihai), Kahlmeter, G. (Gunnar), Meletiadis, J. (Joseph), Guinea, J., Arendrup, M.C. (M. C.), Guinea, J. (J.), Friberg, N. (N.), Mares, M. (M.), Kahlmeter, G., Andersen, C.T. (C. T.), Barchiesi, F. (F.), Chryssanthou, E. (E.), Hamal, P. (P.), Järv, H. (H.), Klimko, N. (N.), Kurzai, O. (O.), Lagrou, K. (Katrien), Lass-Flörl, C. (Cornelia), Matos, T. (T.), Muehlethaler, K. (K.), Rogers, T.R. (Thomas), Velegraki, A. (A.)
المصدر: Cidara Therapeutics (Cidara); Cidara Therapeutics (Cidara); Gilead Sciences (Gilead); Gilead Sciences (Gilead); Gilead Sciences (Gilead); Gilead Sciences (Gilead); Gilead Sciences (Gilead); Gilead Sciences (Gilead); Gilead Sciences (Gilead); Gilead Sciences (Gilead); Meso Scale Diagnostics (MSD); Meso Scale Diagnostics (MSD); Meso Scale Diagnostics (MSD); Astellas Pharma US; Astellas Pharma US; Astellas Pharma US; Astellas Pharma US; Basilea Pharmaceutica; Basilea Pharmaceutica; MSD K.K.; MSD K.K.; MSD K.K.; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer
مصطلحات الفهرس: amphotericin B, Aspergillus, azoles, breakpoint, Candida, echinocandins, ECOFF, EUCAST, Intermediate, MIC, microdilution, Resistant, Susceptible, Susceptible Increased exposure, info:eu-repo/semantics/other
-
4مورد إلكتروني
المؤلفون: Arendrup, M. C., Friberg, N., Mares, M., Kahlmeter, G., Meletiadis, J., Guinea, J., Andersen, C. T., Arikan, S., Barchiesi, F., Chryssanthou, E., Hamal, P., Järv, H., Klimko, N., Kurzai, O., Lagrou, K., Lass-Flörl, C., Matos, T., Muehlethaler, K., Rogers, T. R., Velegraki, A.
المصدر: Arendrup , M C , Friberg , N , Mares , M , Kahlmeter , G , Meletiadis , J , Guinea , J , Andersen , C T , Arikan , S , Barchiesi , F , Chryssanthou , E , Hamal , P , Järv , H , Klimko , N , Kurzai , O , Lagrou , K , Lass-Flörl , C , Matos , T , Muehlethaler , K , Rogers , T R , Velegraki , A & Arikan , S 2020 , ' How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST) ' , Clinical Microbiology and Infection , vol. 26 , no. 11 , pp. 1464-1472 .
مصطلحات الفهرس: Amphotericin B, Aspergillus, Azoles, Breakpoint, Candida, Echinocandins, Intermediate, Resistant, Susceptible, Susceptible increased exposure, article
URL:
https://curis.ku.dk/portal/da/publications/how-to-interpret-mics-of-antifungal-compounds-according-to-the-revised-clinical-breakpoints-v-100-european-committee-on-antimicrobial-susceptibility-testing-eucast(e3722163-0e96-4f0d-aea4-9638ad65bff5).html https://doi.org/10.1016/j.cmi.2020.06.007 -
5مورد إلكتروني
المؤلفون: Arendrup, MC, Friberg, N, Mares, M, Kahlmeter, G, Meletiadis, Joseph, Guinea, J, Andersen, CT, Arikan-Akdagli, S, Barchiesi, F, Chryssanthou, E, Hamal, P, Järv, H, Klimko, N, Kurzai, O, Lagrou, K, Lass-Flörl, C, Matos, T, Muehlethaler, K, Rogers, TR, Velegraki, A, Arikan, S
المصدر: Arendrup , MC , Friberg , N , Mares , M , Kahlmeter , G , Meletiadis , J , Guinea , J , Andersen , CT , Arikan-Akdagli , S , Barchiesi , F , Chryssanthou , E , Hamal , P , Järv , H , Klimko , N , Kurzai , O , Lagrou , K , Lass-Flörl , C , Matos , T , Muehlethaler , K , Rogers , TR , Velegraki , A & Arikan , S 2020 , ' How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST) ' , Clinical Microbiology and Infection , vol. 26 , no. 11 , pp. 1464-1472 .
مصطلحات الفهرس: dk/atira/pure/keywords/researchprograms/AFL001000/EMCMM042801; name=EMC MM-04-28-01, dk/atira/pure/keywords/researchprograms/AFL001000/EMCOR01; name=EMC OR-01, article
-
6
-
7مورد إلكتروني
المؤلفون: Guinea, J., Verweij, P. E., Meletiadis, J., Mouton, J. W., Barchiesi, F., Arendrup, M. C., Arikan-Akdagli, S., Castanheira, M., Chryssanthou, E., Friberg, N., Järv, H., Klimko, N., Kurzai, O., Lagrou, K., Lass-Flörl, C., Mares, M., Matos, T., Moore, C. B., Muehlethaler, K., Rogers, T. R., Andersen, C. T., Velegraki, A.
المصدر: Guinea , J , Verweij , P E , Meletiadis , J , Mouton , J W , Barchiesi , F , Arendrup , M C , Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST) , Arikan-Akdagli , S , Castanheira , M , Chryssanthou , E , Friberg , N , Järv , H , Klimko , N , Kurzai , O , Lagrou , K , Lass-Flörl , C , Mares , M , Matos , T , Moore , C B , Muehlethaler , K , Rogers , T R , Andersen , C T & Velegraki , A 2019 , ' How to : EUCAST recommendations on the screening procedure E.Def 10.1 for the detection of azole resistance in Aspergillus fumigatus isolates using four-well azole-containing agar plates ' , Clinical Microbiology and Infection , vol. 25 , no. 6 , pp. 681-687 .
مصطلحات الفهرس: Agar-plate screening, Aspergillus fumigatus, Azole-resistance, EUCAST E.Def 10.1, Screening, article
URL:
https://curis.ku.dk/portal/da/publications/how-to(edd936e8-5d9c-45a3-adea-8dc663aa1dec).html https://doi.org/10.1016/j.cmi.2018.09.008 -
8دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
9
-
10دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.